A Randomized, Double-blind, Double-dummy, Placebo Controlled Three-period Incomplete Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine on Total Nasal Symptom Score in Allergic Rhinitis Patients in an Environmental Exposure Chamber.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Cetirizine; QAV 680
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 06 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Apr 2010 New trial record